A multidisciplinary committee of international experts have released a new clinical practice guideline on the diagnosis of adult hypersensitivity pneumonitis, an immune-mediated inflammatory lung and small airway disease.
As a central goal of PF Awareness Month and their ongoing work, the Pulmonary Fibrosis Foundation aims to improve diagnostic delays and misdiagnoses in this patient population.
Individuals with pulmonary fibrosis could develop more serious complications if infected with COVID-19, and those awaiting organ transplantation and other surgical interventions may face delays because of the pandemic.
A study compared the diagnostic accuracy of endobronchial OCT in interstitial lung disease to the clinical judgment of blinded, independent pathologists and pulmonologists.
Investigators assessed the effect of pirfenidone and nintedanib on the risk for acute exacerbation of idiopathic pulmonary fibrosis in patients undergoing treatment with these antifibrotic agents.
Investigators describe current practices and clinical characteristics of patients with chronic obstructive pulmonary disease undergoing home mechanical ventilation.
Researchers assessed mortality rates in rheumatoid arthritis-related interstitial lung disease as well as the association between mortality, radiographic patterns, and confounding factors.
Because the 2 antifibrotics in use — pirfenidone and nintedanib — have differing mechanisms of action, when one is ineffective the other may provide benefit, thus improving survival.
